At a glance
ClinicalIndex Comparison RecordN/ACompleted· 52 enrolled
Drug / intervention
encoscopic retrograde cholangio-pancreatography, extracorporeal shock wave lithotripsyprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective Cohort Study of Large Pancreatic Radiolucent Stone
In Brief
An observational study evaluating encoscopic retrograde cholangio-pancreatography, extracorporeal shock wave lithotripsy for Chronic Pancreatitis. Completed, enrolled 52 participants.
Detailed Summary
Treatment strategy of chronic pancreatitis (CP) patients with large pancreatic radiolucent stone (≥ 5mm) has not been established. We aimed to figure out clinical features and efficacy of endotherapy for large pancreatic radiolucent stone.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Pancreatitis
Countries--
Collaborators--
Timeline
N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartMar 2011
Primary CompletionDec 2018
Study CompletionJan 2020
First PostedNov 2020
TodayJul 2026
First PostedNov 13, 2020
Enrollment StartMar 1, 2011
Primary CompletionDec 30, 2018
Study CompletionJan 30, 2020
TodayJul 2, 2026
Enrollment to primary: 7.8 yearsPosted 5.6 years ago
Interventions
encoscopic retrograde cholangio-pancreatography, extracorporeal shock wave lithotripsyprocedure